A microRNA expression ratio defining the invasive phenotype in bladder tumors

Urologic Oncology: Seminars and Original Investigations

Volumn 28, Issue 1, 2010, Pages 39-48

  Neely, Lori A ^a   Rieger Christ, Kimberly M ^b   Neto, Brasil Silva ^b   Eroshkin, Alexey ^a   Garver, Joanne ^a   Patel, Sonal ^a   Phung, Nu Ai ^a   McLaughlin, Stephen ^a   Libertino, John A ^b   Whitney, Duncan ^a   Summerhayes, Ian C ^b  

^a US Genomics   (United States)

^b LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Bladder cancer; microRNAs; Single molecule detection

Indexed keywords

MICRORNA;

ARTICLE; BLADDER TUMOR; CANCER GENETICS; CANCER INVASION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SUPERFICIAL CANCER;

AGED; CELL LINE, TUMOR; FEMALE; HUMANS; MALE; MICRORNAS; NEOPLASM INVASIVENESS; PHENOTYPE; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 72549110532     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2008.06.006     Document Type: Article

References (46)

1. Wu X.R. Urothelial tumorigenesis: A tale of divergent pathways. Nat Rev Cancer 5 (2005) 713-725
2. Mitra A.P., Datar R.H., and Cote R.J. Molecular pathways in invasive bladder cancer: New insights into mechanisms, progression, and target identification. J Clin Oncol 24 (2006) 5552-5564
3. Dyrskjot L., Thykjaer T., Kruhoffer M., et al. Identifying distinct classes of bladder carcinoma using microarrays. Nat Genet 33 (2003) 90-96
4. Dyrskjot L., Kruhoffer M., Thykjaer T., et al. Gene expression in the urinary bladder: A common carcinoma in situ gene expression signature exists disregarding histopathological classification. Cancer Res 64 (2004) 4040-4048
5. Aaboe M., Marcussen N., Jensen K.M., et al. Gene expression profiling of noninvasive primary urothelial tumours using microarrays. Br J Cancer 93 (2005) 1182-1190
6. Elsamman E., Fukumori T., Ewis A.A., et al. Differences in gene expression between noninvasive and invasive transitional cell carcinoma of the human bladder using complementary deoxyribonucleic acid microarray: Preliminary results. Urol Oncol 24 (2006) 109-115
7. Thykjaer T., Workman C., Kruhoffer M., et al. Identification of gene expression patterns in superficial and invasive human bladder cancer. Cancer Res 61 (2001) 2492-2499
8. Sanchez-Carbayo M., Socci N.D., Charytonowicz E., et al. Molecular profiling of bladder cancer using cDNA microarrays: Defining histogenesis and biological phenotypes. Cancer Res 62 (2002) 6973-6980
9. Modlich O., Prisack H.B., Pitschke G., et al. Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: Use of cDNA array analysis of gene expression profiles. Clin Cancer Res 10 (2004) 3410-3421
10. Wild P.J., Herr A., Wissmann C., et al. Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder. Clin Cancer Res 11 (2005) 4415-4429
11. Blaveri E., Brewer J.L., Roydasgupta R., et al. Bladder cancer stage and outcome by array-based comparative genomic hybridization. Clin Cancer Res 11 (2005) 7012-7022
12. Blaveri E., Simko J.P., Korkola J.E., et al. Bladder cancer outcome and subtype classification by gene expression. Clin Cancer Res 11 (2005) 4044-4055
13. Dyrskjot L., Zieger K., Kruhoffer M., et al. A molecular signature in superficial bladder carcinoma predicts clinical outcome. Clin Cancer Res 11 (2005) 4029-4036
14. Sanchez-Carbayo M., Socci N.D., Lozano J., et al. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J Clin Oncol 24 (2006) 778-789
15. Takata R., Katagiri T., Kanehira M., et al. Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling. Clin Cancer Res 11 (2005) 2625-2636
16. Kent O.A., and Mendell J.T. A small piece in the cancer puzzle: MicroRNAs as tumor suppressors and oncogenes. Oncogene 25 (2006) 6188-6196
17. Esquela-Kerscher A., and Slack F.J. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6 (2006) 259-269
18. Calin G.A., and Croce C.M. MicroRNA signatures in human cancers. Nat Rev Cancer 6 (2006) 857-866
19. Kusenda B., Mraz M., Mayer J., et al. MicroRNA biogenesis, functionality and cancer relevance. Biomed Pap Med Fac Univ Palacky Olomouc Czecho Repub 150 (2006) 205-215
20. Johnson C.D., Esquela-Kerscher A., Stefani G., et al. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 67 (2007) 7713-7722
21. Chan J.A., Krichevsky A.M., and Kosik K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65 (2005) 6029-6033
22. Hayashita Y., Osada H., Tatematsu Y., et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65 (2005) 9628-9632
23. Si M.L., Zhu S., Wu H., et al. miR-21-mediated tumor growth. Oncogene 26 (2007) 2799-2803
24. Chen Y., and Stallings R.L. Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res 67 (2007) 976-983
25. Porkka K.P., Pfeiffer M.J., Waltering K.K., et al. MicroRNA expression profiling in prostate cancer. Cancer Res 67 (2007) 6130-6135
26. Iorio M.V., Ferracin M., Liu C.G., et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65 (2005) 7065-7070
27. Lu J., Getz G., Miska E.A., et al. MicroRNA expression profiles classify human cancers. Nature 435 (2005) 834-838
28. Yanaihara N., Caplen N., Bowman E., et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9 (2006) 189-198
29. Volinia S., Calin G.A., Liu C.G., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103 (2006) 2257-2261
30. Bloomston M., Frankel W.L., Petrocca F., et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297 (2007) 1901-1908
31. Roldo C., Missiaglia E., Hagan J.P., et al. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 24 (2006) 4677-4684
32. Ma L., Teruya-Feldstein J., and Weinberg R.A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449 (2007) 682-688
33. Saito Y., Liang G., Egger G., et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9 (2006) 435-443
34. Meng F., Henson R., Lang M., et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130 (2006) 2113-2129
35. Seo J., and Shneiderman B. Knowledge discovery in high-dimensional data: Case studies and a user survey for the rank-by-feature framework. IEEE Trans Vis Comput Graph 12 (2006) 311-322
36. Neely L.A., Patel S., Garver J., et al. A single-molecule method for the quantitation of microRNA gene expression. Nat Methods 3 (2006) 41-46
37. Neely L.A., Patel S., Garver J., et al. A single-molecule method for the quantitation of microRNA gene expression. Nat Methods 3 (2006) 41-46
38. Tran N., McLean T., Zhang X., et al. MicroRNA expression profiles in head and neck cancer cell lines. Biochem Biophys Res Commun 358 (2007) 12-17
39. Dalmay T., and Edwards D.R. MicroRNAs and the hallmarks of cancer. Oncogene 25 (2006) 6170-6175
40. Meng F., Henson R., Wehbe-Janek H., et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133 (2007) 647-658
41. Zhu S., Si M.L., Wu H., et al. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). Journal Biol Chem 282 (2007) 14328-14336
42. Catto J.W., Xinarianos G., Burton J.L., et al. Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability. Int J Cancer 105 (2003) 484-490
43. Oeggerli M., Tomovska S., Schraml P., et al. E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer. Oncogene 23 (2004) 5616-5623
44. Feber A., Clark J., Goodwin G., et al. Amplification and overexpression of E2F3 in human bladder cancer. Oncogene 23 (2004) 1627-1630
45. Zavadil J., Narasimhan M., Blumenberg M., et al. Transforming growth factor-beta and microRNA:mRNA regulatory networks in epithelial plasticity. Cells Tissues Organs 185 (2007) 157-161
46. Baumgart E., Cohen M.S., Neto B.S., et al. Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors. Clin Cancer Res 13 (2007) 1685-1694